Table of Content

1 Pet Meds and Supplements Market Overview
1.1 Product Overview and Scope of Pet Meds and Supplements
1.2 Pet Meds and Supplements Segment by Type
1.2.1 Global Pet Meds and Supplements Market Value Comparison by Type (2024-2034)
1.2.2 External Use
1.2.3 Oral Use
1.3 Pet Meds and Supplements Segment by Application
1.3.1 Global Pet Meds and Supplements Market Value by Application: (2024-2034)
1.3.2 Dogs
1.3.3 Cats
1.3.4 Rabbit
1.3.5 Bird
1.3.6 Others
1.4 Global Pet Meds and Supplements Market Size Estimates and Forecasts
1.4.1 Global Pet Meds and Supplements Revenue 2018-2034
1.4.2 Global Pet Meds and Supplements Sales 2018-2034
1.4.3 Global Pet Meds and Supplements Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Pet Meds and Supplements Market Competition by Manufacturers
2.1 Global Pet Meds and Supplements Sales Market Share by Manufacturers (2018-2024)
2.2 Global Pet Meds and Supplements Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Pet Meds and Supplements Average Price by Manufacturers (2018-2024)
2.4 Global Pet Meds and Supplements Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Pet Meds and Supplements, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pet Meds and Supplements, Product Type & Application
2.7 Pet Meds and Supplements Market Competitive Situation and Trends
2.7.1 Pet Meds and Supplements Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pet Meds and Supplements Players Market Share by Revenue
2.7.3 Global Pet Meds and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pet Meds and Supplements Retrospective Market Scenario by Region
3.1 Global Pet Meds and Supplements Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Pet Meds and Supplements Global Pet Meds and Supplements Sales by Region: 2018-2034
3.2.1 Global Pet Meds and Supplements Sales by Region: 2018-2024
3.2.2 Global Pet Meds and Supplements Sales by Region: 2024-2034
3.3 Global Pet Meds and Supplements Global Pet Meds and Supplements Revenue by Region: 2018-2034
3.3.1 Global Pet Meds and Supplements Revenue by Region: 2018-2024
3.3.2 Global Pet Meds and Supplements Revenue by Region: 2024-2034
3.4 North America Pet Meds and Supplements Market Facts & Figures by Country
3.4.1 North America Pet Meds and Supplements Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Pet Meds and Supplements Sales by Country (2018-2034)
3.4.3 North America Pet Meds and Supplements Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pet Meds and Supplements Market Facts & Figures by Country
3.5.1 Europe Pet Meds and Supplements Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Pet Meds and Supplements Sales by Country (2018-2034)
3.5.3 Europe Pet Meds and Supplements Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pet Meds and Supplements Market Facts & Figures by Country
3.6.1 Asia Pacific Pet Meds and Supplements Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Pet Meds and Supplements Sales by Country (2018-2034)
3.6.3 Asia Pacific Pet Meds and Supplements Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pet Meds and Supplements Market Facts & Figures by Country
3.7.1 Latin America Pet Meds and Supplements Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Pet Meds and Supplements Sales by Country (2018-2034)
3.7.3 Latin America Pet Meds and Supplements Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pet Meds and Supplements Market Facts & Figures by Country
3.8.1 Middle East and Africa Pet Meds and Supplements Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Pet Meds and Supplements Sales by Country (2018-2034)
3.8.3 Middle East and Africa Pet Meds and Supplements Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pet Meds and Supplements Sales by Type (2018-2034)
4.1.1 Global Pet Meds and Supplements Sales by Type (2018-2024)
4.1.2 Global Pet Meds and Supplements Sales by Type (2024-2034)
4.1.3 Global Pet Meds and Supplements Sales Market Share by Type (2018-2034)
4.2 Global Pet Meds and Supplements Revenue by Type (2018-2034)
4.2.1 Global Pet Meds and Supplements Revenue by Type (2018-2024)
4.2.2 Global Pet Meds and Supplements Revenue by Type (2024-2034)
4.2.3 Global Pet Meds and Supplements Revenue Market Share by Type (2018-2034)
4.3 Global Pet Meds and Supplements Price by Type (2018-2034)
5 Segment by Application
5.1 Global Pet Meds and Supplements Sales by Application (2018-2034)
5.1.1 Global Pet Meds and Supplements Sales by Application (2018-2024)
5.1.2 Global Pet Meds and Supplements Sales by Application (2024-2034)
5.1.3 Global Pet Meds and Supplements Sales Market Share by Application (2018-2034)
5.2 Global Pet Meds and Supplements Revenue by Application (2018-2034)
5.2.1 Global Pet Meds and Supplements Revenue by Application (2018-2024)
5.2.2 Global Pet Meds and Supplements Revenue by Application (2024-2034)
5.2.3 Global Pet Meds and Supplements Revenue Market Share by Application (2018-2034)
5.3 Global Pet Meds and Supplements Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Corporation Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Boehringer Ingelheim Pet Meds and Supplements Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Ceva Sante Animale
6.2.1 Ceva Sante Animale Corporation Information
6.2.2 Ceva Sante Animale Description and Business Overview
6.2.3 Ceva Sante Animale Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Ceva Sante Animale Pet Meds and Supplements Product Portfolio
6.2.5 Ceva Sante Animale Recent Developments/Updates
6.3 Bimeda Animal Health
6.3.1 Bimeda Animal Health Corporation Information
6.3.2 Bimeda Animal Health Description and Business Overview
6.3.3 Bimeda Animal Health Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Bimeda Animal Health Pet Meds and Supplements Product Portfolio
6.3.5 Bimeda Animal Health Recent Developments/Updates
6.4 Dechra Pharmaceuticals
6.4.1 Dechra Pharmaceuticals Corporation Information
6.4.2 Dechra Pharmaceuticals Description and Business Overview
6.4.3 Dechra Pharmaceuticals Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Dechra Pharmaceuticals Pet Meds and Supplements Product Portfolio
6.4.5 Dechra Pharmaceuticals Recent Developments/Updates
6.5 Zoetis
6.5.1 Zoetis Corporation Information
6.5.2 Zoetis Description and Business Overview
6.5.3 Zoetis Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Zoetis Pet Meds and Supplements Product Portfolio
6.5.5 Zoetis Recent Developments/Updates
6.6 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Merck Pet Meds and Supplements Product Portfolio
6.6.5 Merck Recent Developments/Updates
6.7 Elanco
6.6.1 Elanco Corporation Information
6.6.2 Elanco Description and Business Overview
6.6.3 Elanco Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Elanco Pet Meds and Supplements Product Portfolio
6.7.5 Elanco Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Bayer Pet Meds and Supplements Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Boehringer
6.9.1 Boehringer Corporation Information
6.9.2 Boehringer Description and Business Overview
6.9.3 Boehringer Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Boehringer Pet Meds and Supplements Product Portfolio
6.9.5 Boehringer Recent Developments/Updates
6.10 Novartis
6.10.1 Novartis Corporation Information
6.10.2 Novartis Description and Business Overview
6.10.3 Novartis Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Novartis Pet Meds and Supplements Product Portfolio
6.10.5 Novartis Recent Developments/Updates
6.11 Virbac
6.11.1 Virbac Corporation Information
6.11.2 Virbac Pet Meds and Supplements Description and Business Overview
6.11.3 Virbac Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Virbac Pet Meds and Supplements Product Portfolio
6.11.5 Virbac Recent Developments/Updates
6.12 Ceva
6.12.1 Ceva Corporation Information
6.12.2 Ceva Pet Meds and Supplements Description and Business Overview
6.12.3 Ceva Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Ceva Pet Meds and Supplements Product Portfolio
6.12.5 Ceva Recent Developments/Updates
6.13 Vetoquinol
6.13.1 Vetoquinol Corporation Information
6.13.2 Vetoquinol Pet Meds and Supplements Description and Business Overview
6.13.3 Vetoquinol Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Vetoquinol Pet Meds and Supplements Product Portfolio
6.13.5 Vetoquinol Recent Developments/Updates
6.14 Nexvet
6.14.1 Nexvet Corporation Information
6.14.2 Nexvet Pet Meds and Supplements Description and Business Overview
6.14.3 Nexvet Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Nexvet Pet Meds and Supplements Product Portfolio
6.14.5 Nexvet Recent Developments/Updates
6.15 Aratana Therapeutics
6.15.1 Aratana Therapeutics Corporation Information
6.15.2 Aratana Therapeutics Pet Meds and Supplements Description and Business Overview
6.15.3 Aratana Therapeutics Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Aratana Therapeutics Pet Meds and Supplements Product Portfolio
6.15.5 Aratana Therapeutics Recent Developments/Updates
6.16 Kindred Biosciences
6.16.1 Kindred Biosciences Corporation Information
6.16.2 Kindred Biosciences Pet Meds and Supplements Description and Business Overview
6.16.3 Kindred Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Kindred Biosciences Pet Meds and Supplements Product Portfolio
6.16.5 Kindred Biosciences Recent Developments/Updates
6.17 Ambrx
6.17.1 Ambrx Corporation Information
6.17.2 Ambrx Pet Meds and Supplements Description and Business Overview
6.17.3 Ambrx Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Ambrx Pet Meds and Supplements Product Portfolio
6.17.5 Ambrx Recent Developments/Updates
6.18 Entest Biomedical
6.18.1 Entest Biomedical Corporation Information
6.18.2 Entest Biomedical Pet Meds and Supplements Description and Business Overview
6.18.3 Entest Biomedical Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.18.4 Entest Biomedical Pet Meds and Supplements Product Portfolio
6.18.5 Entest Biomedical Recent Developments/Updates
6.19 Taconic Biosciences
6.19.1 Taconic Biosciences Corporation Information
6.19.2 Taconic Biosciences Pet Meds and Supplements Description and Business Overview
6.19.3 Taconic Biosciences Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Taconic Biosciences Pet Meds and Supplements Product Portfolio
6.19.5 Taconic Biosciences Recent Developments/Updates
6.20 Dechra Veterinary Products
6.20.1 Dechra Veterinary Products Corporation Information
6.20.2 Dechra Veterinary Products Pet Meds and Supplements Description and Business Overview
6.20.3 Dechra Veterinary Products Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Dechra Veterinary Products Pet Meds and Supplements Product Portfolio
6.20.5 Dechra Veterinary Products Recent Developments/Updates
6.21 Ouro Fino Saude
6.21.1 Ouro Fino Saude Corporation Information
6.21.2 Ouro Fino Saude Pet Meds and Supplements Description and Business Overview
6.21.3 Ouro Fino Saude Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.21.4 Ouro Fino Saude Pet Meds and Supplements Product Portfolio
6.21.5 Ouro Fino Saude Recent Developments/Updates
6.22 Norbrook
6.22.1 Norbrook Corporation Information
6.22.2 Norbrook Pet Meds and Supplements Description and Business Overview
6.22.3 Norbrook Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Norbrook Pet Meds and Supplements Product Portfolio
6.22.5 Norbrook Recent Developments/Updates
6.23 Frontline
6.23.1 Frontline Corporation Information
6.23.2 Frontline Pet Meds and Supplements Description and Business Overview
6.23.3 Frontline Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Frontline Pet Meds and Supplements Product Portfolio
6.23.5 Frontline Recent Developments/Updates
6.24 Zesty Paws
6.24.1 Zesty Paws Corporation Information
6.24.2 Zesty Paws Pet Meds and Supplements Description and Business Overview
6.24.3 Zesty Paws Pet Meds and Supplements Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Zesty Paws Pet Meds and Supplements Product Portfolio
6.24.5 Zesty Paws Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pet Meds and Supplements Industry Chain Analysis
7.2 Pet Meds and Supplements Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pet Meds and Supplements Production Mode & Process
7.4 Pet Meds and Supplements Sales and Marketing
7.4.1 Pet Meds and Supplements Sales Channels
7.4.2 Pet Meds and Supplements Distributors
7.5 Pet Meds and Supplements Customers
8 Pet Meds and Supplements Market Dynamics
8.1 Pet Meds and Supplements Industry Trends
8.2 Pet Meds and Supplements Market Drivers
8.3 Pet Meds and Supplements Market Challenges
8.4 Pet Meds and Supplements Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Pet Meds and Supplements Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Pet Meds and Supplements Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Pet Meds and Supplements Market Competitive Situation by Manufacturers in 2022
Table 4. Global Pet Meds and Supplements Sales (Units) of Key Manufacturers (2018-2024)
Table 5. Global Pet Meds and Supplements Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Pet Meds and Supplements Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Pet Meds and Supplements Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Pet Meds and Supplements Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Pet Meds and Supplements, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Pet Meds and Supplements, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pet Meds and Supplements, Product Type & Application
Table 12. Global Key Manufacturers of Pet Meds and Supplements, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pet Meds and Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Meds and Supplements as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pet Meds and Supplements Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Pet Meds and Supplements Sales by Region (2018-2024) & (Units)
Table 18. Global Pet Meds and Supplements Sales Market Share by Region (2018-2024)
Table 19. Global Pet Meds and Supplements Sales by Region (2024-2034) & (Units)
Table 20. Global Pet Meds and Supplements Sales Market Share by Region (2024-2034)
Table 21. Global Pet Meds and Supplements Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Pet Meds and Supplements Revenue Market Share by Region (2018-2024)
Table 23. Global Pet Meds and Supplements Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Pet Meds and Supplements Revenue Market Share by Region (2024-2034)
Table 25. North America Pet Meds and Supplements Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Pet Meds and Supplements Sales by Country (2018-2024) & (Units)
Table 27. North America Pet Meds and Supplements Sales by Country (2024-2034) & (Units)
Table 28. North America Pet Meds and Supplements Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Pet Meds and Supplements Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Pet Meds and Supplements Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Pet Meds and Supplements Sales by Country (2018-2024) & (Units)
Table 32. Europe Pet Meds and Supplements Sales by Country (2024-2034) & (Units)
Table 33. Europe Pet Meds and Supplements Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Pet Meds and Supplements Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Pet Meds and Supplements Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Pet Meds and Supplements Sales by Region (2018-2024) & (Units)
Table 37. Asia Pacific Pet Meds and Supplements Sales by Region (2024-2034) & (Units)
Table 38. Asia Pacific Pet Meds and Supplements Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Pet Meds and Supplements Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Pet Meds and Supplements Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Pet Meds and Supplements Sales by Country (2018-2024) & (Units)
Table 42. Latin America Pet Meds and Supplements Sales by Country (2024-2034) & (Units)
Table 43. Latin America Pet Meds and Supplements Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Pet Meds and Supplements Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Pet Meds and Supplements Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Pet Meds and Supplements Sales by Country (2018-2024) & (Units)
Table 47. Middle East & Africa Pet Meds and Supplements Sales by Country (2024-2034) & (Units)
Table 48. Middle East & Africa Pet Meds and Supplements Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Pet Meds and Supplements Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Pet Meds and Supplements Sales (Units) by Type (2018-2024)
Table 51. Global Pet Meds and Supplements Sales (Units) by Type (2024-2034)
Table 52. Global Pet Meds and Supplements Sales Market Share by Type (2018-2024)
Table 53. Global Pet Meds and Supplements Sales Market Share by Type (2024-2034)
Table 54. Global Pet Meds and Supplements Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Pet Meds and Supplements Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Pet Meds and Supplements Revenue Market Share by Type (2018-2024)
Table 57. Global Pet Meds and Supplements Revenue Market Share by Type (2024-2034)
Table 58. Global Pet Meds and Supplements Price (US$/Unit) by Type (2018-2024)
Table 59. Global Pet Meds and Supplements Price (US$/Unit) by Type (2024-2034)
Table 60. Global Pet Meds and Supplements Sales (Units) by Application (2018-2024)
Table 61. Global Pet Meds and Supplements Sales (Units) by Application (2024-2034)
Table 62. Global Pet Meds and Supplements Sales Market Share by Application (2018-2024)
Table 63. Global Pet Meds and Supplements Sales Market Share by Application (2024-2034)
Table 64. Global Pet Meds and Supplements Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Pet Meds and Supplements Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Pet Meds and Supplements Revenue Market Share by Application (2018-2024)
Table 67. Global Pet Meds and Supplements Revenue Market Share by Application (2024-2034)
Table 68. Global Pet Meds and Supplements Price (US$/Unit) by Application (2018-2024)
Table 69. Global Pet Meds and Supplements Price (US$/Unit) by Application (2024-2034)
Table 70. Boehringer Ingelheim Corporation Information
Table 71. Boehringer Ingelheim Description and Business Overview
Table 72. Boehringer Ingelheim Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Boehringer Ingelheim Pet Meds and Supplements Product
Table 74. Boehringer Ingelheim Recent Developments/Updates
Table 75. Ceva Sante Animale Corporation Information
Table 76. Ceva Sante Animale Description and Business Overview
Table 77. Ceva Sante Animale Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Ceva Sante Animale Pet Meds and Supplements Product
Table 79. Ceva Sante Animale Recent Developments/Updates
Table 80. Bimeda Animal Health Corporation Information
Table 81. Bimeda Animal Health Description and Business Overview
Table 82. Bimeda Animal Health Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Bimeda Animal Health Pet Meds and Supplements Product
Table 84. Bimeda Animal Health Recent Developments/Updates
Table 85. Dechra Pharmaceuticals Corporation Information
Table 86. Dechra Pharmaceuticals Description and Business Overview
Table 87. Dechra Pharmaceuticals Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Dechra Pharmaceuticals Pet Meds and Supplements Product
Table 89. Dechra Pharmaceuticals Recent Developments/Updates
Table 90. Zoetis Corporation Information
Table 91. Zoetis Description and Business Overview
Table 92. Zoetis Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Zoetis Pet Meds and Supplements Product
Table 94. Zoetis Recent Developments/Updates
Table 95. Merck Corporation Information
Table 96. Merck Description and Business Overview
Table 97. Merck Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Merck Pet Meds and Supplements Product
Table 99. Merck Recent Developments/Updates
Table 100. Elanco Corporation Information
Table 101. Elanco Description and Business Overview
Table 102. Elanco Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Elanco Pet Meds and Supplements Product
Table 104. Elanco Recent Developments/Updates
Table 105. Bayer Corporation Information
Table 106. Bayer Description and Business Overview
Table 107. Bayer Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Bayer Pet Meds and Supplements Product
Table 109. Bayer Recent Developments/Updates
Table 110. Boehringer Corporation Information
Table 111. Boehringer Description and Business Overview
Table 112. Boehringer Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Boehringer Pet Meds and Supplements Product
Table 114. Boehringer Recent Developments/Updates
Table 115. Novartis Corporation Information
Table 116. Novartis Description and Business Overview
Table 117. Novartis Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Novartis Pet Meds and Supplements Product
Table 119. Novartis Recent Developments/Updates
Table 120. Virbac Corporation Information
Table 121. Virbac Description and Business Overview
Table 122. Virbac Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Virbac Pet Meds and Supplements Product
Table 124. Virbac Recent Developments/Updates
Table 125. Ceva Corporation Information
Table 126. Ceva Description and Business Overview
Table 127. Ceva Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Ceva Pet Meds and Supplements Product
Table 129. Ceva Recent Developments/Updates
Table 130. Vetoquinol Corporation Information
Table 131. Vetoquinol Description and Business Overview
Table 132. Vetoquinol Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Vetoquinol Pet Meds and Supplements Product
Table 134. Vetoquinol Recent Developments/Updates
Table 135. Nexvet Corporation Information
Table 136. Nexvet Description and Business Overview
Table 137. Nexvet Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Nexvet Pet Meds and Supplements Product
Table 139. Nexvet Recent Developments/Updates
Table 140. Aratana Therapeutics Corporation Information
Table 141. Aratana Therapeutics Description and Business Overview
Table 142. Aratana Therapeutics Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Aratana Therapeutics Pet Meds and Supplements Product
Table 144. Aratana Therapeutics Recent Developments/Updates
Table 145. Kindred Biosciences Corporation Information
Table 146. Kindred Biosciences Description and Business Overview
Table 147. Kindred Biosciences Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Kindred Biosciences Pet Meds and Supplements Product
Table 149. Kindred Biosciences Recent Developments/Updates
Table 150. Ambrx Corporation Information
Table 151. Ambrx Description and Business Overview
Table 152. Ambrx Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Ambrx Pet Meds and Supplements Product
Table 154. Ambrx Recent Developments/Updates
Table 155. Entest Biomedical Corporation Information
Table 156. Entest Biomedical Description and Business Overview
Table 157. Entest Biomedical Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Entest Biomedical Pet Meds and Supplements Product
Table 159. Entest Biomedical Recent Developments/Updates
Table 160. Taconic Biosciences Corporation Information
Table 161. Taconic Biosciences Description and Business Overview
Table 162. Taconic Biosciences Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Taconic Biosciences Pet Meds and Supplements Product
Table 164. Taconic Biosciences Recent Developments/Updates
Table 165. Dechra Veterinary Products Corporation Information
Table 166. Dechra Veterinary Products Description and Business Overview
Table 167. Dechra Veterinary Products Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Dechra Veterinary Products Pet Meds and Supplements Product
Table 169. Dechra Veterinary Products Recent Developments/Updates
Table 170. Ouro Fino Saude Corporation Information
Table 171. Ouro Fino Saude Description and Business Overview
Table 172. Ouro Fino Saude Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. Ouro Fino Saude Pet Meds and Supplements Product
Table 174. Ouro Fino Saude Recent Developments/Updates
Table 175. Norbrook Corporation Information
Table 176. Norbrook Description and Business Overview
Table 177. Norbrook Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Norbrook Pet Meds and Supplements Product
Table 179. Norbrook Recent Developments/Updates
Table 180. Frontline Corporation Information
Table 181. Frontline Description and Business Overview
Table 182. Frontline Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Frontline Pet Meds and Supplements Product
Table 184. Frontline Recent Developments/Updates
Table 185. Zesty Paws Corporation Information
Table 186. Zesty Paws Description and Business Overview
Table 187. Zesty Paws Pet Meds and Supplements Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Zesty Paws Pet Meds and Supplements Product
Table 189. Zesty Paws Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Pet Meds and Supplements Distributors List
Table 193. Pet Meds and Supplements Customers List
Table 194. Pet Meds and Supplements Market Trends
Table 195. Pet Meds and Supplements Market Drivers
Table 196. Pet Meds and Supplements Market Challenges
Table 197. Pet Meds and Supplements Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pet Meds and Supplements
Figure 2. Global Pet Meds and Supplements Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Pet Meds and Supplements Market Share by Type in 2022 & 2034
Figure 4. External Use Product Picture
Figure 5. Oral Use Product Picture
Figure 6. Global Pet Meds and Supplements Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Pet Meds and Supplements Market Share by Application in 2022 & 2034
Figure 8. Dogs
Figure 9. Cats
Figure 10. Rabbit
Figure 11. Bird
Figure 12. Others
Figure 13. Global Pet Meds and Supplements Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Pet Meds and Supplements Market Size (2018-2034) & (US$ Million)
Figure 15. Global Pet Meds and Supplements Sales (2018-2034) & (Units)
Figure 16. Global Pet Meds and Supplements Average Price (US$/Unit) & (2018-2034)
Figure 17. Pet Meds and Supplements Report Years Considered
Figure 18. Pet Meds and Supplements Sales Share by Manufacturers in 2022
Figure 19. Global Pet Meds and Supplements Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest Pet Meds and Supplements Players: Market Share by Revenue in 2022
Figure 21. Pet Meds and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global Pet Meds and Supplements Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 23. North America Pet Meds and Supplements Sales Market Share by Country (2018-2034)
Figure 24. North America Pet Meds and Supplements Revenue Market Share by Country (2018-2034)
Figure 25. U.S. Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Canada Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Europe Pet Meds and Supplements Sales Market Share by Country (2018-2034)
Figure 28. Europe Pet Meds and Supplements Revenue Market Share by Country (2018-2034)
Figure 29. Germany Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. France Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. U.K. Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Italy Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Russia Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Asia Pacific Pet Meds and Supplements Sales Market Share by Region (2018-2034)
Figure 35. Asia Pacific Pet Meds and Supplements Revenue Market Share by Region (2018-2034)
Figure 36. China Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Japan Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. South Korea Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. India Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Australia Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Taiwan Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Indonesia Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Thailand Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Malaysia Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Philippines Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Latin America Pet Meds and Supplements Sales Market Share by Country (2018-2034)
Figure 47. Latin America Pet Meds and Supplements Revenue Market Share by Country (2018-2034)
Figure 48. Mexico Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Argentina Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Pet Meds and Supplements Sales Market Share by Country (2018-2034)
Figure 52. Middle East & Africa Pet Meds and Supplements Revenue Market Share by Country (2018-2034)
Figure 53. Turkey Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. U.A.E Pet Meds and Supplements Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Pet Meds and Supplements by Type (2018-2034)
Figure 57. Global Revenue Market Share of Pet Meds and Supplements by Type (2018-2034)
Figure 58. Global Pet Meds and Supplements Price (US$/Unit) by Type (2018-2034)
Figure 59. Global Sales Market Share of Pet Meds and Supplements by Application (2018-2034)
Figure 60. Global Revenue Market Share of Pet Meds and Supplements by Application (2018-2034)
Figure 61. Global Pet Meds and Supplements Price (US$/Unit) by Application (2018-2034)
Figure 62. Pet Meds and Supplements Value Chain
Figure 63. Pet Meds and Supplements Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed